Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000049873 | SCV000792043 | likely pathogenic | Finnish congenital nephrotic syndrome | 2017-06-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001376868 | SCV001574054 | pathogenic | not provided | 2023-09-20 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 15 of the NPHS1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in NPHS1 are known to be pathogenic (PMID: 11317351, 11854170, 12039988). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with clinical features of nephrotic syndrome (PMID: 11317351, 20507940, 34859019). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 56460). For these reasons, this variant has been classified as Pathogenic. |
Vasylyeva lab, |
RCV003407432 | SCV004123137 | likely pathogenic | Infantile Nephrotic syndrome | 2022-09-26 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000049873 | SCV004191386 | pathogenic | Finnish congenital nephrotic syndrome | 2023-10-17 | criteria provided, single submitter | clinical testing | |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000049873 | SCV000082282 | probable-pathogenic | Finnish congenital nephrotic syndrome | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |